GoodRx offers Ozempic pill for diabetes patients starting at $149
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq fall as megacap tech drags; Iran developments watched
- Oil falls 4% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
- Sanuwave cuts Q2 2026 revenue guidance amid Ultramist sales pressure
GoodRx Expands Offerings to Now Include Ozempic® Pill for Type 2 Diabetes Patients
May 1, 2026 8:10 AM EDTEligible self-pay patients can access the oral diabetes treatment for as low as $149 per month
Brief Summary:
GoodRx expands access to Ozempic® pill (oral semaglutide) for as low as $149 per month Available at GoodRxs nationwide pharmacy network Adds an oral option to the Ozempic treatment portfolioSANTA MONICA, Calif.--(BUSINESS WIRE)-- GoodRx (Nasdaq: GDRX), the leading platform for prescription savings in the U.S., today announced that it is providing access to self-pay pricing for Novo... More
